1. Home
  2. GXO vs TLX Comparison

GXO vs TLX Comparison

Compare GXO & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GXO
  • TLX
  • Stock Information
  • Founded
  • GXO 2021
  • TLX 2015
  • Country
  • GXO United States
  • TLX Australia
  • Employees
  • GXO N/A
  • TLX N/A
  • Industry
  • GXO Transportation Services
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GXO Consumer Discretionary
  • TLX Health Care
  • Exchange
  • GXO Nasdaq
  • TLX Nasdaq
  • Market Cap
  • GXO 4.8B
  • TLX 4.0B
  • IPO Year
  • GXO N/A
  • TLX N/A
  • Fundamental
  • Price
  • GXO $52.66
  • TLX $9.51
  • Analyst Decision
  • GXO Buy
  • TLX Strong Buy
  • Analyst Count
  • GXO 13
  • TLX 3
  • Target Price
  • GXO $60.62
  • TLX $22.33
  • AVG Volume (30 Days)
  • GXO 1.2M
  • TLX 211.5K
  • Earning Date
  • GXO 08-05-2025
  • TLX 01-01-0001
  • Dividend Yield
  • GXO N/A
  • TLX N/A
  • EPS Growth
  • GXO N/A
  • TLX N/A
  • EPS
  • GXO 0.53
  • TLX 0.04
  • Revenue
  • GXO $12,683,000,000.00
  • TLX $664,225,558.00
  • Revenue This Year
  • GXO $13.66
  • TLX N/A
  • Revenue Next Year
  • GXO $6.14
  • TLX N/A
  • P/E Ratio
  • GXO $98.67
  • TLX $223.97
  • Revenue Growth
  • GXO 22.39
  • TLX 55.35
  • 52 Week Low
  • GXO $30.46
  • TLX $9.48
  • 52 Week High
  • GXO $63.33
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • GXO 54.21
  • TLX 31.15
  • Support Level
  • GXO $52.73
  • TLX $12.12
  • Resistance Level
  • GXO $53.86
  • TLX $12.58
  • Average True Range (ATR)
  • GXO 1.39
  • TLX 0.45
  • MACD
  • GXO -0.08
  • TLX 0.01
  • Stochastic Oscillator
  • GXO 48.12
  • TLX 0.98

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: